Breakthrough test could predict lung cancer recurrence before it happens
NCT ID NCT05557474
Summary
This study is testing two new diagnostic kits designed to identify which early-stage lung cancer patients are at highest risk of recurrence after surgery. Researchers will validate these tests on 236 patients who have undergone complete tumor removal. The goal is to create tools that help doctors predict which patients need closer monitoring or additional treatment after surgery.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SURGERY are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Chung Shan Medical University Hospital
RECRUITINGTaichung, Taiwan, 402, Taiwan
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
National Taiwan University, Cancer Center
RECRUITINGTaipei, 106, Taiwan
Contact
Conditions
Explore the condition pages connected to this study.